These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8087659)

  • 1. Incidence and risk factors for latent sensitization to chymopapain: predictive skin-prick tests in 700 candidates for chemonucleolysis.
    Moneret-Vautrin DA; Feldmann L; Kanny G; Baumann A; Roland J; Pere P
    Clin Exp Allergy; 1994 May; 24(5):471-6. PubMed ID: 8087659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergy to chymopapain: value of predictive tests before chemonucleolysis].
    Moneret-Vautrin DA; Benoist M; Laxenaire MC; Croizier A; Guéant JL
    Ann Fr Anesth Reanim; 1985; 4(3):313-5. PubMed ID: 3893237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitization to chymopapain in patients treated with chemonucleolysis].
    García-Ortega P; Ramírez Ferreiras W; Sancho A; Urías S; Cisteró A
    Med Clin (Barc); 1991 Mar; 96(11):410-2. PubMed ID: 2046428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin tests and chymopapain-specific immunoglobulins E after chemonucleolysis].
    Cornaille G; Guérin B; Leynadier F; Menkes CJ; Dry J
    Presse Med; 1987 May; 16(18):881-4. PubMed ID: 2954117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin testing for chymopapain allergy in chemonucleolysis.
    Mayer HM; Wehr M; Brock M; Kaden B
    Surg Neurol; 1986 Mar; 25(3):283-9. PubMed ID: 3945910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chymopapain allergy. Diagnostic value of a skin test before and after chemonucleolysis].
    Mayer HM; Brock M
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):51-6. PubMed ID: 3887196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Dolovich J; Schatz M; Zeiger R; Cogen F; Shaughnessy JJ; Chandler MJ
    Clin Orthop Relat Res; 1987 Aug; (221):202-6. PubMed ID: 3608299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Cogen F; Dolovich J; Schatz M; Zeiger R; Shaughnessy JJ; Gutt L
    Clin Orthop Relat Res; 1988 Sep; (234):12-5. PubMed ID: 3409565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and prevention of allergic reactions following chemonucleolysis with chymopapain].
    Mayer HM
    Neurochirurgia (Stuttg); 1986 Sep; 29 Suppl 1():149-53. PubMed ID: 3491335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin tests for chymopapain allergy.
    McCulloch JA; Canham WD; Dolovich J
    Ann Allergy; 1985 Oct; 55(4):609-11. PubMed ID: 4051266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat chymopapain injections. Results and complications.
    Schweigel JF; Berezowskyj J
    Spine (Phila Pa 1976); 1987 Oct; 12(8):800-2. PubMed ID: 3686235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year results from chemonucleolysis with chymopapain or collagenase: a prospective randomized study.
    Wittenberg RH; Oppel S; Rubenthaler FA; Steffen R
    Spine (Phila Pa 1976); 2001 Sep; 26(17):1835-41. PubMed ID: 11568690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis.
    Bernstein DI; Gallagher JS; Ulmer A; Bernstein IL
    J Allergy Clin Immunol; 1985 Sep; 76(3):458-65. PubMed ID: 3897344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in plasma histamine and catecholamines levels after injection of chymopapain in chemonucleolysis].
    Occelli G; Raucoules M; Philip F; Lapalus P; Candito M; Grimaud D
    Ann Fr Anesth Reanim; 1991; 10(6):516-21. PubMed ID: 1785700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of patients at risk of allergy to chymopapain before and after chemonucleolysis. Choice of preventive medication].
    Castagnera L; Maurette P; Macouillard G; Lavignolle B
    Acta Orthop Belg; 1987; 53(2):213-20. PubMed ID: 3687407
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective study of risk factors in natural rubber latex hypersensitivity.
    Moneret-Vautrin DA; Beaudouin E; Widmer S; Mouton C; Kanny G; Prestat F; Kohler C; Feldmann L
    J Allergy Clin Immunol; 1993 Nov; 92(5):668-77. PubMed ID: 8227857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 17% prevalence of anaphylaxis during chemonucleolysis among 35 patients who underwent a repeat chemonucleolysis procedure.
    Bernstein IL; Bernstein DI
    Spine (Phila Pa 1976); 1988 Jan; 13(1):135. PubMed ID: 3381129
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemonucleolysis. Personal history, trials, and tribulations.
    Smith L
    Clin Orthop Relat Res; 1993 Feb; (287):117-24. PubMed ID: 8448928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chymopapain induced allergic reactions.
    Bernstein DI; Bernstein IL
    Clin Rev Allergy; 1986 May; 4(2):201-13. PubMed ID: 3516360
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic and therapeutic technology assessment. Chemonucleolysis for herniated lumbar disk.
    JAMA; 1989 Aug; 262(7):953-6. PubMed ID: 2666684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.